Halozyme Therapeutics, Inc. (HALO)
NASDAQ: HALO · Real-Time Price · USD
49.00
+3.30 (7.22%)
At close: Nov 22, 2024, 4:00 PM
49.51
+0.51 (1.04%)
After-hours: Nov 22, 2024, 6:19 PM EST

Halozyme Therapeutics Employees

Halozyme Therapeutics had 373 employees as of December 31, 2023. The number of employees decreased by 20 or -5.09% compared to the previous year.

Employees
373
Change (1Y)
-20
Growth (1Y)
-5.09%
Revenue / Employee
$2,539,826
Profits / Employee
$1,052,190
Market Cap
6.23B

Employees Chart

Employees History

Date Employees Change Growth
Dec 31, 2023373-20-5.09%
Dec 31, 2022393248171.03%
Dec 31, 202114596.62%
Dec 31, 202013643.03%
Dec 31, 2019132-149-53.02%
Dec 31, 20182812610.20%
Dec 31, 2017255-4-1.54%
Dec 31, 20162594319.91%
Dec 31, 20152166341.18%
Dec 31, 2014153-17-10.00%
Dec 31, 20131701811.84%
Dec 31, 20121521712.59%
Dec 31, 20111353332.35%
Dec 31, 2010102-38-27.14%
Dec 31, 2009140107.69%
Dec 31, 20081303841.30%
Dec 31, 20079252130.00%
Dec 31, 200640--
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.